Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day...
Guardado en:
Autores principales: | Wang-Da Liu, Chien-Ching Hung, Jann-Tay Wang, Ming-Jui Tsai, Po-Hsien Kuo, Tai-Ling Chao, Szu-Min Hsieh, Wang-Huei Sheng, Yee-Chun Chen, Sui-Yuan Chang, Shan-Chwen Chang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c68ae0190b84843af686b82c3f5a65f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inmunodiagnóstico de las infecciones por Strongyloides stercoralis en Chile utilizando la prueba de ELISA
por: Mercado P,Rubén, et al.
Publicado: (2002) -
The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
por: Joshua Yang, et al.
Publicado: (2021) -
Prueba de Elisa en deposición para detectar infección por Helicobacter pylori
por: Morales B,Antonio, et al.
Publicado: (2002) -
Seroprevalence of Chikungunya (CHIK) Infection during Non Epidemic Periods in Chennai, Southern India
por: Kaliyamoorthy Kayalvili, et al.
Publicado: (2021) -
Diagnosis of rubella virus using antigen-conjugated Au@Pt nanorods as nanozyme probe
por: Zhang T, et al.
Publicado: (2018)